CAU
AVNS icon

Caxton Associates (UK)’s Avanos Medical AVNS Stock Holding History

Caxton Associates (UK)’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,116
Closed -$389K – 696
2025
Q1 		$389K Buy
+27,116
New +$423K 0.01% 554

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Caxton Associates (UK)'s AVNS Position: Q2 2025 in Review

Caxton Associates (UK) sold out of Avanos Medical (AVNS) in Q2 2025, closing a stake of 27,116 shares — an estimated $389K sold.

Caxton Associates (UK) first reported a position in AVNS in Q1 2025 and held it in 1 quarter. The position peaked at $389K in Q1 2025. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2025.

  • Caxton Associates (UK) reported no remaining Avanos Medical position as of Q2 2025 after selling out during the quarter.
  • Caxton Associates (UK) sold 27,116 Avanos Medical shares in Q2 2025, an estimated $389K.
  • Caxton Associates (UK) first reported a position in Avanos Medical in Q1 2025 and held it in 1 quarter.
  • Caxton Associates (UK)'s Avanos Medical position peaked at $389K in Q1 2025.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2025.

Based on Caxton Associates (UK)'s 13F filing for Q2 2025, filed 15 Aug 2025.